View drug registration information details.
Items | Registration information |
ID | 372 |
No | 372 |
Brand Name | V-GAVIR 450 |
Ingredients | VALGANCICLOVIR HCL USP EQ.TO VALGANCICLOVIR 450 MG |
Dosage Form | FILM-COATED TABLETS |
Primary Packaging | ALU-STRIP |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 5 X 4'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | FOR THE INDUCTION AND MAINTENANCE TREATMENT OF CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME, FOR THE PREVENTION OF CMV DISEASE IN CMV-NEGATIVE PATIENTS WHO HAVE RECEIVED A SOLID ORGAN TRANSPLANT FROM A CMV-POSITIVE DONOR |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | DARK BROWN COLOURED, CAPSULE SHAPED BICONVEX, FILM COATED TABLETS |
Note | |
License Owner | CBF PHARMA CO.,LTD |
Manufacturer | UNITED BIOTECH (P) LIMITED |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 06 I 4943/20 |
FDD Registration Date | 14-AUG-2023 |
Expiry Date | 13-AUG-2026 |
Back to drug list
|